Cover news trainee reporter Zhao Zijun
At noon on December 1, when Liu Fangbin walked out of the hospital, he was relieved and finally ended nearly 3 years of acute promyelocytic leukemia treatment, and he happily informed all his friends of the good news of his own recovery. The day after he was discharged from the hospital, Liu Fangbin returned to the hospital, but this time to thank the medical staff who took good care of him during the hospitalization, he sent four pennants to the hospital, "thanking them very much."
Who would have thought that this Luzhou boy who had been fighting leukemia for three years was only 25 years old this year and had already experienced a life-and-death test. On December 8, the cover news reporter interviewed Liu Fangbin and his tube bed doctor Tang Jirui, and gained an in-depth understanding of Liu Fangbin's three-year leukemia struggle history and the treatment process of acute promyelocytic leukemia.
Acute promyelocytic leukemia was diagnosed at the age of 22
Hospitalized 21 times Fighting leukemia for almost 3 years
At the end of October 2018, 22-year-old Liu Fangbin suddenly found that he often had bleeding gums and blood clots in his throat when he slept at night, "The symptoms lasted for about 10 days, and I was outside to pack the construction site, so I didn't pay attention." In early December, these symptoms appeared on Liu Fangbin again. In addition, Liu Fangbin's body also appeared egg-sized purple patches, "I felt that something was wrong at that time." Subsequently, Liu Fangbin went to the Affiliated Hospital of Southwest Medical University.
On December 22, 2018, Liu Fangbin clearly remembered this date, on this day, he was diagnosed with acute promyelocytic leukemia. Although he had been vaguely aware of his condition a few days ago, when he was accurately informed of his condition and needed to be hospitalized, Liu Fangbin still shed tears, "I think God is so unfair." But Liu Fangbin quickly adjusted his mentality, "Work hard, persistence is victory, I hope all the bad will end in 2018!" Liu Fangbin lay on the hospital bed silently cheering himself up.
Liu Fangbin's circle of friends on December 24, 2018
After that, Liu Fangbin began his own history of fighting leukemia. On the second day of hospitalization, Liu Fangbin was judged to be in the high-risk group of acute promyelocytic leukemia, "This was the most serious situation, I had a platelet transfusion for about 2 weeks in a row. Fortunately, under the active treatment of the hospital, Liu Fangbin's condition has been alleviated and his condition has gradually improved.
Finally, after the 21st hospitalization, after undergoing induction therapy, consolidation therapy, maintenance therapy and other processes, Liu Fangbin's illness was cured. During hospitalization, he underwent 6 lumbar punctures and intrathecal injection of chemotherapy drugs to prevent central nervous system leukemia. "Later, I will return to the hospital regularly for examinations, the first year is once every three months, the second year is once every six months, and the next is once every three years."
Doctor: A blessing in disguise
Acute promyelocytic leukemia is curative
"If our hospital suspects that the patient is acute promyelocytic leukemia, we will open a green channel, immediately improve the bone marrow, gene, and chromosome examination, generally within 24 hours of reporting, and arrange treatment as soon as possible." Tang Jirui of the Department of Hematology of the Affiliated Hospital of Southwest Medical University is one of Liu Fangbin's tube bed doctors, and Dr. Tang Jirui told reporters that the early bleeding symptoms of acute promyelocytic leukemia are severe, and intracranial hemorrhage and diffuse intravascular coagulation may endanger the lives of patients. "Liu Fangbin's initial treatment process is about a month, which is the highest risk month, in order to reduce the risk of bleeding, in this process we injected him with a large number of platelets and cryoprecipitates. After the end of the first course of treatment, his condition reached a remission and reached the therapeutic goal we expected. ”
In order to consolidate the therapeutic effect, the hospital subsequently carried out 3 courses of consolidation chemotherapy for Liu Fangbin. "At the end of each course of treatment, the bone marrow and genes were reviewed to achieve remission. Eventually meet the discharge criteria. ”
When it comes to leukemia, many people may think of "death" for the first time, but Dr. Tang Jirui told reporters that acute promyelocytic leukemia is a curable leukemia, "This is a more common type of disease, in our doctor's view, acute promyelocytic leukemia is a blessing in misfortune, it is a subtype of leukemia with better treatment effect, generally do not need to do hematopoietic stem cell transplantation, drug treatment can be." After the end of consolidation therapy, oral tretinoin and compound yellow daisy tablets can be maintained, and the outpatient follow-up of the department can be followed up, and the blood routine and bone marrow can be reviewed regularly. Tang Jirui introduced.
Dr. Tang Jirui reminded that if there is bleeding gums, oral bleeding, nasal bleeding, or extensive ecchymosis and petechiae on the skin, it is necessary to register with the hematology clinic as soon as possible for blood routine and coagulation tests.